Brandman J - Search Results

1

A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new users.

Simon JA, Wysocki S, Brandman J, Axelsen K. Simon JA, et al. Among authors: brandman j. Menopause. 2003 Jan-Feb;10(1):37-44. doi: 10.1097/00042192-200310010-00007. Menopause. 2003. PMID: 12544675

2

Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.

Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL. Smith MR, et al. Among authors: brandman j. J Clin Oncol. 2005 Nov 1;23(31):7897-903. doi: 10.1200/JCO.2004.00.6908. J Clin Oncol. 2005. PMID: 16258089

3

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer.

Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Smith MR, et al. Among authors: brandman j. J Urol. 2006 Jan;175(1):136-9; discussion 139. doi: 10.1016/S0022-5347(05)00033-9. J Urol. 2006. PMID: 16406890

4

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy.

Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS. Krupski TL, et al. Among authors: brandman j. Cancer. 2004 Aug 1;101(3):541-9. doi: 10.1002/cncr.20388. Cancer. 2004. PMID: 15274067 Free article.

5

Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases.

Botteman M, Barghout V, Stephens J, Hay J, Brandman J, Aapro M. Botteman M, et al. Among authors: brandman j. Ann Oncol. 2006 Jul;17(7):1072-82. doi: 10.1093/annonc/mdl093. Epub 2006 May 2. Ann Oncol. 2006. PMID: 16670202 Free article.

6

The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.

Delea T, Langer C, McKiernan J, Liss M, Edelsberg J, Brandman J, Sung J, Raut M, Oster G. Delea T, et al. Among authors: brandman j. Oncology. 2004;67(5-6):390-6. doi: 10.1159/000082923. Oncology. 2004. PMID: 15713995

7

Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.

Delea T, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G. Delea T, et al. Among authors: brandman j. J Support Oncol. 2006 Jul-Aug;4(7):341-7. J Support Oncol. 2006. PMID: 16892696

8

Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.

Delea TE, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G. Delea TE, et al. Among authors: brandman j. J Thorac Oncol. 2006 Jul;1(6):571-6. J Thorac Oncol. 2006. PMID: 17409919 Free article.

9

Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.

El Ouagari K, Karnon J, Delea T, Talbot W, Brandman J. El Ouagari K, et al. Among authors: brandman j. Breast Cancer Res Treat. 2007 Jan;101(1):37-49. doi: 10.1007/s10549-006-9262-4. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821085

10

Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.

Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE. Delea TE, et al. Among authors: brandman j. Am J Manag Care. 2006 Jul;12(7):374-86. Am J Manag Care. 2006. PMID: 16834524 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters